|
1
|
Jemal A, Bray F, Center MM, et al: Global
cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Glück S and Gorouhi F: Clinical and
economic benefits of aromatase inhibitor therapy in early-stage
breast cancer. Am J Health Syst Pharm. 68:1699–1706.
2011.PubMed/NCBI
|
|
3
|
Noto A, Raffa S, De Vitis C, et al:
Stearoyl-CoA desaturase-1 is a key factor for lung
cancer-initiating cells. Cell Death Dis. 4:e9472013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xia P, Gou WF, Zhao S and Zheng HC:
Crizotinib may be used in Lewis lung carcinoma: A novel use for
crizotinib. Oncol Rep. 30:139–148. 2013.PubMed/NCBI
|
|
6
|
Ho MM, Ng AV, Lam S and Hung JY: Side
population in human lung cancer cell lines and tumors is enriched
with stem-like cancer cells. Cancer Res. 67:4827–4833. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Haraguchi N, Utsunomiya T, Inoue H, et al:
Characterization of a side population of cancer cells from human
gastrointestinal system. Stem Cells. 24:506–513. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schiller JH, Harrington D, Belani CP, et
al: Comparison of four chemotherapy regimens for advanced
non-small-cell lung cancer. N Engl J Med. 346:92–98. 2002.
View Article : Google Scholar
|
|
9
|
Spielmann M, Llombart-Cussac A, Kalla S,
et al: Single-agent gemcitabine is active in previously treated
breast cancer. Oncology. 60:303–307. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Plunkett W, Huang P, Xu YZ, et al:
Gemcitabine: metabolism, mechanisms of action, and
self-potentiation. Semin Oncol. 22(Suppl 11): S3–S10. 1995.
|
|
11
|
Chatterjee K, Zhang J, Honbo N and
Karliner JS: Doxorubicin cardiomyopathy. Cardiology. 115:155–162.
2010. View Article : Google Scholar
|
|
12
|
Takemura G and Fujiwara H:
Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms
to management. Prog Cardiovasc Dis. 49:330–352. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gibbs CP, Kukekov VG, Reith JD, et al:
Stem-like cells in bone sarcomas: implications for tumorigenesis.
Neoplasia. 7:967–976. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu J, Peng H and Zhang JT: Human multidrug
transporter ABCG2, a target for sensitizing drug resistance in
cancer chemotherapy. Curr Med Chem. 14:689–701. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang JT: Biochemistry and pharmacology of
the human multidrug resistance gene product, ABCG2. Zhong Nan Da
Xue Xue Bao Yi Xue Ban. 32:531–541. 2007.PubMed/NCBI
|
|
16
|
Kanzaki A, Toi M, Neamati N, et al:
Copper-transporting P-type adenosine triphosphatase (ATP7B) is
expressed in human breast carcinoma. Jpn J Cancer Res. 93:70–77.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Robey RW, Ierano C, Zhan Z and Bates SE:
The challenge of exploiting ABCG2 in the clinic. Curr Pharm
Biotechnol. 12:595–608. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou J, Wang CY, Liu T, et al: Persistence
of side population cells with high drug efflux capacity in
pancreatic cancer. World J Gastroenterol. 14:925–930. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bergman AM, Pinedo HM, Talianidis I, et
al: Increased sensitivity to gemcitabine of P-glycoprotein and
multidrug resistance-associated protein-overexpressing human cancer
cell lines. Br J Cancer. 88:1963–1970. 2003. View Article : Google Scholar
|
|
20
|
Nobili S, Landini I, Giglioni B and Mini
E: Pharmacological strategies for overcoming multidrug resistance.
Curr Drug Targets. 7:861–879. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu ZH and Lenardo MJ: Reactive oxygen
species regulate autophagy through redox-sensitive proteases. Dev
Cell. 12:484–485. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xia P, Gou WF, Wang JJ, et al: Distinct
radiosensitivity of lung carcinoma stem-like side population and
main population cells. Cancer Biother Radiopharm. 28:471–478. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xing YN, Deng P and Xu HM: Canstatin
induces apoptosis in gastric cancer xenograft growth in mice
through mitochondrial apoptotic pathway. Biosci Rep. Apr
2–2014.(Epub ahead of print).
|
|
24
|
Phillips TM, McBride WH and Pajonk F: The
response of CD24−/low/CD44+ breast
cancer-initiating cells to radiation. J Natl Cancer Inst.
98:1777–1785. 2006.PubMed/NCBI
|
